BMC Infectious Diseases Infectious Diseases

Illness trajectory in the longer term after hospitalisation for COVID-19: a prospective, multicentre cohort study

Anna Kamdar, Andrew J. Morrow, Robert Sykes, Alasdair McIntosh, Catherine Bagot, Hannah K. Bayes, Kevin G. Blyth, Colin Church, Lynsey Gillespie, Giles Roditi, David Stobo, Sarah Weeden, Paul Welsh, Kenneth Mangion, Alex McConnachie, Colin Berry, on behalf of the CISCO-19 Consortium
Springer Nature · 2026-01-20 · DOI 10.1186/s12879-025-12487-w

Abstract

Abstract Background There are few data on the longer-term illness trajectory of patients following hospitalisation for COVID-19. Methods We prospectively enrolled 267 adults hospitalised for COVID-19. Longer-term follow up was available for 260 participants. Event rates for death or unplanned hospitalisation were calculated using a Poisson model. Univariate and multivariable analyses identified baseline predictors, with a backward selection process for the best fitting model. Results The mean age of COVID-19 participants was 54.9±12.1 years, and 41% were female. During median follow-up of 1028 days (IQR:1000,1085), 112 individuals (43.1%) had at least one event including 6 deaths (2.3%). There were 252 events in total. The first event rate was 18.9 per 100 person-years (95%CI: 15.7, 22.8). Multivariable predictors included healthcare worker status (HR 0.59, 95%CI: 0.34, 1.02, p=0.046), Charlson Comorbidity Index (HR 1.13, 95%CI: 1.02, 1.24, p=0.020), current smoking (HR 2.49, 95%CI: 1.21, 5.11, p=0.010), and haemoglobin (HR 0.93, 95%CI: 0.88, 0.99, p=0.020). The WHO Clinical Severity Score was not a significant predictor (p=0.187). Conclusion Comorbidity, current smoking status and haemoglobin predict illness trajectory following hospitalisation for COVID-19, rather than illness severity during hospitalisation. Further research is needed to explore interventions targeting these factors to improve prognosis. Trial registration CISCO-19; http://NCT04403607. Registration date; 23/05/2020

Read at publisher →